Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Futura Medical Plc LSE:FUM London Ordinary Share GB0033278473 ORD 0.2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +1.25p +5.21% 25.25p 25.00p 25.50p 26.50p 24.00p 24.00p 1,276,143 16:28:42
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.0 -7.2 -4.5 - 51.68

Futura Medical Share Discussion Threads

Showing 16101 to 16121 of 16850 messages
Chat Pages: Latest  650  649  648  647  646  645  644  643  642  641  640  639  Older
DateSubjectAuthorDiscuss
13/11/2018
16:46
joecase do you know they are ?
mikethebike4
13/11/2018
14:05
They have bought shares before and lost money.
joestalin
13/11/2018
14:01
I see that the BoD have bought some - I don't suppose they would do this and lose money - so might be a good sign
mikethebike4
12/11/2018
14:51
By reference to the rns
joecase
12/11/2018
14:44
mw how do we know there are any actual 'investors'
mikethebike4
12/11/2018
14:28
It is no wonder that they did not raise the full 1m given that there was no discount to the trading price,indeed last week you could buy shares lower than the offer price.The intriguing question is who are the new institutional Investors?
martinelwick
12/11/2018
09:57
The fun part,you can buy back multiples more for less.I see price normalisation returning as the funding is hours from being passed.Phase 3 trials full speed ahead.20's could return almost as fast as it was lost.Sentiment is everything and can change on a dime.
j777j
12/11/2018
09:53
"Luckily I sold out high 30's after the relentless negativity on this board." Classic J! Every time! On every share. Quite a remarkable feat really. Kudos.
kemche
12/11/2018
09:04
What's Offer to buy Futura share they appears into my treading account??Worth it?
p_dharmendra
11/11/2018
17:08
I've done some research into this. And I've concluded this meets "Einstein's definition of madness". For some holders it also appears to fit the Stockholm Syndrome criteria.
mauricemonkey
10/11/2018
16:57
Iofina management seem superstars compared to this bunch of dullards!! Change needed and fast!!!
escapetohome
09/11/2018
12:02
Let’s hope JB does not blow it this time. I think that we all expect that he will do exactly that.
joestalin
09/11/2018
11:18
Now 4 million shares withdrawn.Nice transparent markets!
j777j
09/11/2018
10:32
Can any one explain how £8000000 shares can be traded without any effect on the share price.On a positive note all the science looks good and we now have the money we need to complete the trial 3 program.Let's hope JB does not blow it this time.
martinelwick
09/11/2018
09:01
It is right it is the safety profile which is same or less even at their highest study dosage.Needs US interest maybe this conference will provide fresh blood.A year away from a potential blockbuster $1billion peak sales forecast)Which if succeeds these will tenbag or more.Just a thought.
j777j
09/11/2018
08:50
seems like it may help to publicize MED2005 but don't understand "In addition, the PK study demonstrated similar or lower bioavailability of GTN when administered via MED2005 compared with Nitrostat(R) at doses 0.2%, 0.4%, and 0.6% GTN." - seems the wrong way round to me as a layman
mikethebike4
09/11/2018
07:48
A bit of news: https://www.investegate.co.uk/futura-medical-plc--fum-/rns/presents-data-on-med2005-at-smsna-annual-meeting/201811090700028447G/
arthur_lame_stocks
08/11/2018
18:15
So are you staying that this news headline is not True?Lombard Odier Asset Management Cuts Stake In Futura Medical To 11% (ALLISS)
j777j
07/11/2018
19:29
I just don't like people who blatantly lie to suit their own agenda, weildy2, hence my abruptness. Despite my own criticism of FUM, I think MED is very promising but Barder is useless. However, FUM are stuck with him as it will cost a fortune to get rid and FUM could end up with another Barder anyway. We all thought the SSL/RB deal at first was potentially lucrative but its death proved that licensing doesn't work. The irony is that the deal COST FUM millions as they waited for RB to do something. Lesson learnt? No. Same happened with Church & Dwight. And rather than raise funds to progress MED to the finished article Barder wasted time and money yet again to chase another pointless licensing partner, diluting the shares massively in the process. It beggars belief. There's still a fair amount of hope for healthy returns on current share price but LTHs have been shafted by bad management.
jonnybig
07/11/2018
14:03
This has nowhere to go but down. Nothing to look out for. Thanks for nothing mr. Barder.
greedfear
07/11/2018
10:26
A stopped clock is right twice every day.
joestalin
Chat Pages: Latest  650  649  648  647  646  645  644  643  642  641  640  639  Older
Your Recent History
LSE
FUM
Futura Med..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20190525 20:52:31